The traditions and risks of fasting for lipid profiles in patients with diabetes.
Fasting overnight has been traditionally recommended by clinicians when ordering laboratory tests for lipid profiles for the purposes of health screening or monitoring of the effects of lipid-lowering medications. Patients with diabetes are tested for lipid profiles at least annually. This deeply rooted tradition of fasting for lipid testing has recently been challenged. Several studies have shown little benefit obtained by testing lipids in fasting compared with postprandial states. Furthermore, recent studies have shown the importance of postprandial lipid spikes in the pathogenesis of cardiovascular disease. At the same time, recent reports have alerted the medical community to the risk of hypoglycemia in patients with diabetes on antidiabetic medications (particularly insulin and sulfonylureas) who are asked to fast for lab tests. This article reviews the literature on these emerging issues in lipid testing in patients with diabetes, and offers recommendations for lipid testing in these patients in view of these emerging discussions.
Associate Professor of Medicine, Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI.
Saleh
S
Aldasouqi
George
G
Grunberger
D019963:Clinical Chemistry Tests / Q000379:methods* / Q000592:standards / Q000639:trends; D003920:Diabetes Mellitus / Q000175:diagnosis* / Q000503:physiopathology; D005215:Fasting / Q000009:adverse effects / Q000502:physiology*; D006801:Humans; D007003:Hypoglycemia / Q000453:epidemiology; D008055:Lipids / Q000097:blood*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
D008055:Lipids